Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Lemaitre Vascular (LMAT) Operating Income (2016 - 2025)

Lemaitre Vascular (LMAT) has disclosed Operating Income for 16 consecutive years, with -$33.3 million as the latest value for Q4 2025.

  • On a quarterly basis, Operating Income fell 358.99% to -$33.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was $15.8 million, a 69.79% decrease, with the full-year FY2025 number at $15.8 million, down 69.79% from a year prior.
  • Operating Income was -$33.3 million for Q4 2025 at Lemaitre Vascular, down from $20.3 million in the prior quarter.
  • In the past five years, Operating Income ranged from a high of $20.3 million in Q3 2025 to a low of -$33.3 million in Q4 2025.
  • A 5-year average of $8.4 million and a median of $9.3 million in 2023 define the central range for Operating Income.
  • Peak YoY movement for Operating Income: surged 127.96% in 2021, then tumbled 358.99% in 2025.
  • Lemaitre Vascular's Operating Income stood at $8.3 million in 2021, then decreased by 16.07% to $7.0 million in 2022, then skyrocketed by 46.49% to $10.2 million in 2023, then increased by 25.95% to $12.9 million in 2024, then crashed by 358.99% to -$33.3 million in 2025.
  • Per Business Quant, the three most recent readings for LMAT's Operating Income are -$33.3 million (Q4 2025), $20.3 million (Q3 2025), and $16.1 million (Q2 2025).